Man jailed over Enfield Lock killing at drugs factory

Five men in total sentenced over their involvement in July 2020 killing of Skender Ismaili

Ali Coulibaly
Ali Coulibaly (credit Met Police)

A 21-year-old has been jailed for eleven years over the manslaughter of an Enfield Lock man who was fatally stabbed during a burglary at a cannabis factory.

Four other men admitted aggravated burglary in connection with the death of 30-year-old Skender Ismaili, who was killed in the early hours of 17th July 2020 at an address in Lytton Avenue. Three of them have also been jailed.

Skender was involved in the illegal cultivation of cannabis in Enfield Lock but was said by a Met Police detective to have “paid too great a price” for his involvement in the drugs trade.

Ali Coulibaly, aged 21, of Atkinson Road, Newham, pleaded guilty in December 2021 to the manslaughter of Skender, as well as aggravated burglary.

At a sentencing hearing at Woolwich Crown Court on Friday, Coulibaly was handed an eleven-year prison sentence. The four men who admitted aggravated burglary are Mason Harris-Williams, aged 26, who has been jailed for six years and four months; Daniel Fletcher, 21, jailed for five years; Ahmed Yamac, 20, jailed for five years and five months; and Jazeel Lewis, 19, jailed for seven years. Harris-Williams, Fletcher and Lewis are all from Ealing and Yamac is from Feltham.

A sixth defendant, Haseeb Nadeem, aged 20 of Raynes Park, received a two-year suspended sentence for assisting an offender.

Detective Inspector Neil Cramer, from the Metropolitan Police’s specialist command, said: “As a result of a painstaking investigation, five people were charged in connection with either the killing of Skender Ismaili or the associated burglary at Lytton Avenue.

“A sixth was charged with assisting an offender. Such was the weight of evidence against them, they had no option but to enter guilty pleas.

“Mr Ismaili paid too great a price for his involvement in the cultivation of cannabis at the property. Anyone who buys illegal drugs should reflect on this human cost when considering the choices they make around drug use.”